Latest News of HBIO
Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Could Be 50% Below Their Intrinsic Value Estimate
By Yahoo! Finance |
3 months ago
Harvard Bioscience may be undervalued by 50% based on its current share price of US$2.88. Utilizing a Discounted Cash Flow (DCF) model, the intrinsic value was estimated at US$2.9, indicating potentia...
Institutional investors may adopt severe steps after Harvard Bioscience, Inc.'s (NASDAQ:HBIO) latest 13% drop adds to a year losses
By Yahoo! Finance |
3 months ago
Institutional investors hold 65% of Harvard Bioscience, Inc. (NASDAQ:HBIO), influencing stock dynamics. Top 10 investors own 52%, with hedge funds and CEO James Green also holding significant stakes....